Reports in Diseases and conditions would either cover market size and forecasting for disease treatments or for medical devices, instrumentation and durable medical equipment associated with the care for a given disease. Diseases are usually more serious; conditions more common but this terminology is not always followed. Diabetes, Hypertension and Gout are a few examples of diseases. Anemia is a condition in which one has an abnormally low number of red blood cells (RBCs). Anemia also can occur if one’s RBCs don't contain substantial hemoglobin. Hemoglobin is an iron-rich protein that assists RBCs in carrying oxygen from the lungs to the the body. One who has anemia doesn't get enough oxygen-rich blood. As a result, they may feel tired and have other symptoms. Severe or long-lasting anemia can damage the heart, brain, and other organs of the body. Very severe anemia may even cause death. varicose veins are swollen, twisted veins that you can see just under the surface of the skin. These veins usually occur in the legs, but they also can form in other parts of the body. Varicose veins are common. They usually cause few signs and symptoms. Sometimes varicose veins cause mild to moderate pain, blood clots, skin ulcers , or other problems.
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
|
|
|
All reports in Diseases & Conditions
|
Freedonia Focus on Diabetes Monitoring Products: United States
5/31/2012 | published by: Freedonia Focus
... and market forecasts, industry composition, and leading participants. Products covered include blood glucose test strips, lancets and lancing devices, monitors, and other monitoring products. Markets include home healthcare, hospitals, and other markets. This 22 page ...
|
more...
|
$600.00
|
|
Calming and Sleeping in Guatemala
5/10/2012 | published by: Euromonitor International
... country. This market size was reached in 2011 after registering current value growth of 2%. Most OTC calming and sleeping products that are classified as standard include natural active ingredients such as passiflora. Euromonitor International's ...
|
more...
|
$900.00
|
|
Calming and Sleeping in Ukraine
5/10/2012 | published by: Euromonitor International
... signs of stability consumers reverted to convenient and easy to use calming and sleeping products. In 2011, retail value sales increased by 14% in current terms, close to the review period CAGR of 15%, and ...
|
more...
|
$900.00
|
|
Calming and Sleeping in Dominican Republic
5/9/2012 | published by: Euromonitor International
... and home, insomnia, stress and anxiety are commonplace. It is for these reasons that it is common for consumers to turn to use of products for relaxation, calming or which incite sleep. Euromonitor International's Calming ...
|
more...
|
$900.00
|
|
Calming and Sleeping in Latvia
5/8/2012 | published by: Euromonitor International
... using calming and sleeping products was also observed in 2011. In Latvia this trend intensified during the economic crisis in 2009-2010. Considering that younger generation was exposed to the negative economic factors in addition to ...
|
more...
|
$900.00
|
|
Calming and Sleeping in Malaysia
5/3/2012 | published by: Euromonitor International
... report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to ...
|
more...
|
$900.00
|
|
Triple Analysis: Prostate Cancer, Angiogenesis and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Angiogenesis, Cancer Vaccines and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. Below is ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Breast Cancer, Lymphoma and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Breast Cancer, Pancreatic Cancer and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Prostate Cancer, Cancer Vaccines and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Peptides
5/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Peptides
5/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Colorectal Cancer, Cancer Vaccines and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Colorectal Cancer, Leukemia and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Colorectal Cancer, Lung Cancer and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Colorectal Cancer, Melanoma and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Colorectal Cancer, Prostate Cancer and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...
|
more...
|
$5,175.00
|
|
Triple Analysis: Leukemia, Lung Cancer and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...
|
more...
|
$5,175.00
|
|
Calming and Sleeping in Taiwan
5/1/2012 | published by: Euromonitor International
... to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market ...
|
more...
|
$900.00
|


